APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Antiretroviral Protease Inhibitor

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Antiretroviral Protease Inhibitor Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 17396655032 January 2026188 pages

Choose your research edition.

Industry ResearchAntiretroviral Protease Inhibitor Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Antiretroviral Protease Inhibitor Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Antiretroviral Protease Inhibitor Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antiretroviral Protease Inhibitor Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Antiretroviral Protease Inhibitor Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Antiretroviral Protease Inhibitor market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Antiretroviral Protease Inhibitor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Antiretroviral Protease Inhibitor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Antiretroviral Protease Inhibitor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Antiretroviral Protease Inhibitor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Antiretroviral Protease Inhibitor include Merck, AbbVie, Tibotec, Genentech, Inc., Bristol-Myers Squibb and Boehringer Ingelheim, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Antiretroviral Protease Inhibitor market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Antiretroviral Protease Inhibitor and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Antiretroviral Protease Inhibitor sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Antiretroviral Protease Inhibitor market size, projected growth trends, production technologies, key applications, and end-use industries.

Antiretroviral Protease Inhibitor Segment by Company

Merck

AbbVie

Tibotec

Genentech, Inc.

Bristol-Myers Squibb

Boehringer Ingelheim

Antiretroviral Protease Inhibitor Segment by Type

Amino Peptidase Inhibitor

Cysteine Protease Inhibitors

Metallo-Protease Inhibitors

Serine Protease Inhibitors

Aspartic Protease Inhibitors

Others

Antiretroviral Protease Inhibitor Segment by Application

Hospital Pharmacy

Online Pharmacy

Retail Pharmacy

Others

Antiretroviral Protease Inhibitor Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antiretroviral Protease Inhibitor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antiretroviral Protease Inhibitor and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antiretroviral Protease Inhibitor.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Antiretroviral Protease Inhibitor market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Antiretroviral Protease Inhibitor manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Antiretroviral Protease Inhibitor in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Antiretroviral Protease Inhibitor in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Antiretroviral Protease Inhibitor Industry Trends Table 2. Antiretroviral Protease Inhibitor Industry Drivers Table 3. Antiretroviral Protease Inhibitor Industry Opportunities and Challenges Table 4. Antiretroviral Protease Inhibitor Industry Restraints Table 5. Global Antiretroviral Protease Inhibitor Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Antiretroviral Protease Inhibitor Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Antiretroviral Protease Inhibitor Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Antiretroviral Protease Inhibitor Sales Market Share by Manufacturers Table 9. Global Antiretroviral Protease Inhibitor Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Antiretroviral Protease Inhibitor Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Antiretroviral Protease Inhibitor Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Antiretroviral Protease Inhibitor Manufacturers, Product Type & Application Table 13. Global Antiretroviral Protease Inhibitor Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Antiretroviral Protease Inhibitor by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Amino Peptidase Inhibitor Table 17. Major Manufacturers of Cysteine Protease Inhibitors Table 18. Major Manufacturers of Metallo-Protease Inhibitors Table 19. Major Manufacturers of Serine Protease Inhibitors Table 20. Major Manufacturers of Aspartic Protease Inhibitors Table 21. Major Manufacturers of Others Table 22. Global Antiretroviral Protease Inhibitor Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 23. Global Antiretroviral Protease Inhibitor Sales by Type (2021-2026) & (K Units) Table 24. Global Antiretroviral Protease Inhibitor Sales by Type (2027-2032) & (K Units) Table 25. Global Antiretroviral Protease Inhibitor Sales Market Share by Type (2021-2026) Table 26. Global Antiretroviral Protease Inhibitor Sales Market Share by Type (2027-2032) Table 27. Global Antiretroviral Protease Inhibitor Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 28. Global Antiretroviral Protease Inhibitor Revenue by Type (2021-2026) & (K Units) Table 29. Global Antiretroviral Protease Inhibitor Revenue by Type (2027-2032) & (K Units) Table 30. Global Antiretroviral Protease Inhibitor Revenue Market Share by Type (2021-2026) Table 31. Global Antiretroviral Protease Inhibitor Revenue Market Share by Type (2027-2032) Table 32. Major Manufacturers of Hospital Pharmacy Table 33. Major Manufacturers of Online Pharmacy Table 34. Major Manufacturers of Retail Pharmacy Table 35. Major Manufacturers of Others Table 36. Global Antiretroviral Protease Inhibitor Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Antiretroviral Protease Inhibitor Sales by Application (2021-2026) & (K Units) Table 38. Global Antiretroviral Protease Inhibitor Sales by Application (2027-2032) & (K Units) Table 39. Global Antiretroviral Protease Inhibitor Sales Market Share by Application (2021-2026) Table 40. Global Antiretroviral Protease Inhibitor Sales Market Share by Application (2027-2032) Table 41. Global Antiretroviral Protease Inhibitor Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 42. Global Antiretroviral Protease Inhibitor Revenue by Application (2021-2026) & (K Units) Table 43. Global Antiretroviral Protease Inhibitor Revenue by Application (2027-2032) & (K Units) Table 44. Global Antiretroviral Protease Inhibitor Revenue Market Share by Application (2021-2026) Table 45. Global Antiretroviral Protease Inhibitor Revenue Market Share by Application (2027-2032) Table 46. Global Antiretroviral Protease Inhibitor Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 47. Global Antiretroviral Protease Inhibitor Sales by Region (2021-2026) & (K Units) Table 48. Global Antiretroviral Protease Inhibitor Sales Market Share by Region (2021-2026) Table 49. Global Antiretroviral Protease Inhibitor Sales Forecasted by Region (2027-2032) & (K Units) Table 50. Global Antiretroviral Protease Inhibitor Sales Forecasted Market Share by Region (2027-2032) Table 51. North America Antiretroviral Protease Inhibitor Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. North America Antiretroviral Protease Inhibitor Sales by Country (2021-2026) & (K Units) Table 53. North America Antiretroviral Protease Inhibitor Sales by Country (2027-2032) & (K Units) Table 54. Europe Antiretroviral Protease Inhibitor Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Europe Antiretroviral Protease Inhibitor Sales by Country (2021-2026) & (K Units) Table 56. Europe Antiretroviral Protease Inhibitor Sales by Country (2027-2032) & (K Units) Table 57. Asia Pacific Antiretroviral Protease Inhibitor Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. Asia Pacific Antiretroviral Protease Inhibitor Sales by Country (2021-2026) & (K Units) Table 59. Asia Pacific Antiretroviral Protease Inhibitor Sales by Country (2027-2032) & (K Units) Table 60. South America, Middle East and Africa Antiretroviral Protease Inhibitor Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 61. South America, Middle East and Africa Antiretroviral Protease Inhibitor Sales by Country (2021-2026) & (K Units) Table 62. South America, Middle East and Africa Antiretroviral Protease Inhibitor Sales by Country (2027-2032) & (K Units) Table 63. Global Antiretroviral Protease Inhibitor Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 64. Global Antiretroviral Protease Inhibitor Revenue by Region (2021-2026) & (US$ Million) Table 65. Global Antiretroviral Protease Inhibitor Revenue by Region (2027-2032) & (US$ Million) Table 66. Global Antiretroviral Protease Inhibitor Revenue Market Share by Region (2021-2026) Table 67. Global Antiretroviral Protease Inhibitor Revenue Market Share by Region (2027-2032) Table 68. Merck Company Information Table 69. Merck Business Overview Table 70. Merck Antiretroviral Protease Inhibitor Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Merck Antiretroviral Protease Inhibitor Product Portfolio Table 72. Merck Recent Development Table 73. AbbVie Company Information Table 74. AbbVie Business Overview Table 75. AbbVie Antiretroviral Protease Inhibitor Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. AbbVie Antiretroviral Protease Inhibitor Product Portfolio Table 77. AbbVie Recent Development Table 78. Tibotec Company Information Table 79. Tibotec Business Overview Table 80. Tibotec Antiretroviral Protease Inhibitor Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Tibotec Antiretroviral Protease Inhibitor Product Portfolio Table 82. Tibotec Recent Development Table 83. Genentech, Inc. Company Information Table 84. Genentech, Inc. Business Overview Table 85. Genentech, Inc. Antiretroviral Protease Inhibitor Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Genentech, Inc. Antiretroviral Protease Inhibitor Product Portfolio Table 87. Genentech, Inc. Recent Development Table 88. Bristol-Myers Squibb Company Information Table 89. Bristol-Myers Squibb Business Overview Table 90. Bristol-Myers Squibb Antiretroviral Protease Inhibitor Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Bristol-Myers Squibb Antiretroviral Protease Inhibitor Product Portfolio Table 92. Bristol-Myers Squibb Recent Development Table 93. Boehringer Ingelheim Company Information Table 94. Boehringer Ingelheim Business Overview Table 95. Boehringer Ingelheim Antiretroviral Protease Inhibitor Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Boehringer Ingelheim Antiretroviral Protease Inhibitor Product Portfolio Table 97. Boehringer Ingelheim Recent Development Table 98. Key Raw Materials Table 99. Raw Materials Key Suppliers Table 100. Antiretroviral Protease Inhibitor Distributors List Table 101. Antiretroviral Protease Inhibitor Customers List Table 102. Research Programs/Design for This Report Table 103. Authors List of This Report Table 104. Secondary Sources Table 105. Primary Sources List of Figures Figure 1. Antiretroviral Protease Inhibitor Product Image Figure 2. Global Antiretroviral Protease Inhibitor Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antiretroviral Protease Inhibitor Market Size (2021-2032) & (US$ Million) Figure 4. Global Antiretroviral Protease Inhibitor Sales (2021-2032) & (K Units) Figure 5. Global Antiretroviral Protease Inhibitor Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Antiretroviral Protease Inhibitor Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Amino Peptidase Inhibitor Image Figure 9. Cysteine Protease Inhibitors Image Figure 10. Metallo-Protease Inhibitors Image Figure 11. Serine Protease Inhibitors Image Figure 12. Aspartic Protease Inhibitors Image Figure 13. Others Image Figure 14. Global Antiretroviral Protease Inhibitor Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Antiretroviral Protease Inhibitor Sales Market Share 2021 VS 2025 VS 2032 Figure 16. Global Antiretroviral Protease Inhibitor Sales Market Share by Type (2021-2032) Figure 17. Global Antiretroviral Protease Inhibitor Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 18. Global Antiretroviral Protease Inhibitor Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Antiretroviral Protease Inhibitor Revenue Market Share by Type (2021-2032) Figure 20. Hospital Pharmacy Image Figure 21. Online Pharmacy Image Figure 22. Retail Pharmacy Image Figure 23. Others Image Figure 24. Global Antiretroviral Protease Inhibitor Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Antiretroviral Protease Inhibitor Sales Market Share 2021 VS 2025 VS 2032 Figure 26. Global Antiretroviral Protease Inhibitor Sales Market Share by Application (2021-2032) Figure 27. Global Antiretroviral Protease Inhibitor Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 28. Global Antiretroviral Protease Inhibitor Revenue Market Share 2021 VS 2025 VS 2032 Figure 29. Global Antiretroviral Protease Inhibitor Revenue Market Share by Application (2021-2032) Figure 30. North America Antiretroviral Protease Inhibitor Sales and Growth Rate (2021-2032) & (K Units) Figure 31. North America Antiretroviral Protease Inhibitor Sales Market Share by Country (2021-2032) Figure 32. U.S. Antiretroviral Protease Inhibitor Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Canada Antiretroviral Protease Inhibitor Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Mexico Antiretroviral Protease Inhibitor Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Europe Antiretroviral Protease Inhibitor Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Europe Antiretroviral Protease Inhibitor Sales Market Share by Country (2021-2032) Figure 37. Germany Antiretroviral Protease Inhibitor Sales and Growth Rate (2021-2032) & (K Units) Figure 38. France Antiretroviral Protease Inhibitor Sales and Growth Rate (2021-2032) & (K Units) Figure 39. U.K. Antiretroviral Protease Inhibitor Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Italy Antiretroviral Protease Inhibitor Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Netherlands Antiretroviral Protease Inhibitor Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Asia Pacific Antiretroviral Protease Inhibitor Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Asia Pacific Antiretroviral Protease Inhibitor Sales Market Share by Country (2021-2032) Figure 44. China Antiretroviral Protease Inhibitor Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Japan Antiretroviral Protease Inhibitor Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South Korea Antiretroviral Protease Inhibitor Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Southeast Asia Antiretroviral Protease Inhibitor Sales and Growth Rate (2021-2032) & (K Units) Figure 48. India Antiretroviral Protease Inhibitor Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Australia Antiretroviral Protease Inhibitor Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South America, Middle East and Africa Antiretroviral Protease Inhibitor Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South America, Middle East and Africa Antiretroviral Protease Inhibitor Sales Market Share by Country (2021-2032) Figure 52. Brazil Antiretroviral Protease Inhibitor Sales and Growth Rate (2021-2032) & (K Units) Figure 53. South Africa Antiretroviral Protease Inhibitor Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Saudi Arabia Antiretroviral Protease Inhibitor Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Turkey Antiretroviral Protease Inhibitor Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Argentina Antiretroviral Protease Inhibitor Sales and Growth Rate (2021-2032) & (K Units) Figure 57. UAE Antiretroviral Protease Inhibitor Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Egypt Antiretroviral Protease Inhibitor Sales and Growth Rate (2021-2032) & (K Units) Figure 59. Chile Antiretroviral Protease Inhibitor Sales and Growth Rate (2021-2032) & (K Units) Figure 60. Global Antiretroviral Protease Inhibitor Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Global Antiretroviral Protease Inhibitor Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 62. North America Antiretroviral Protease Inhibitor Revenue (2021-2032) & (US$ Million) Figure 63. North America Antiretroviral Protease Inhibitor Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Europe Antiretroviral Protease Inhibitor Revenue (2021-2032) & (US$ Million) Figure 65. Europe Antiretroviral Protease Inhibitor Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Asia-Pacific Antiretroviral Protease Inhibitor Revenue (2021-2032) & (US$ Million) Figure 67. Asia-Pacific Antiretroviral Protease Inhibitor Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. South America, Middle East and Africa Antiretroviral Protease Inhibitor Revenue (2021-2032) & (US$ Million) Figure 69. South America, Middle East and Africa Antiretroviral Protease Inhibitor Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. Antiretroviral Protease Inhibitor Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Antiretroviral Protease Inhibitor Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Amino Peptidase Inhibitor
  • Cysteine Protease Inhibitors
  • Metallo-Protease Inhibitors
  • Serine Protease Inhibitors
  • Aspartic Protease Inhibitors
  • Others
Applications
  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy
  • Others
Companies covered
  • Merck
  • AbbVie
  • Tibotec
  • Genentech, Inc.
  • Bristol-Myers Squibb
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Antiretroviral Protease Inhibitor Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Antiretroviral Protease Inhibitor Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Antiretroviral Protease Inhibitor Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Antiretroviral Protease Inhibitor Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Antiretroviral Protease Inhibitor Market Dynamics
  1. 2.1 Antiretroviral Protease Inhibitor Industry Trends
  2. 2.2 Antiretroviral Protease Inhibitor Industry Drivers
  3. 2.3 Antiretroviral Protease Inhibitor Industry Opportunities and Challenges
  4. 2.4 Antiretroviral Protease Inhibitor Industry Restraints
3 Antiretroviral Protease Inhibitor Market by Manufacturers
  1. 3.1 Global Antiretroviral Protease Inhibitor Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Antiretroviral Protease Inhibitor Sales by Manufacturers (2021-2026)
  3. 3.3 Global Antiretroviral Protease Inhibitor Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Antiretroviral Protease Inhibitor Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Antiretroviral Protease Inhibitor Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Antiretroviral Protease Inhibitor Manufacturers, Product Type & Application
  7. 3.7 Global Antiretroviral Protease Inhibitor Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Antiretroviral Protease Inhibitor Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Antiretroviral Protease Inhibitor Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Antiretroviral Protease Inhibitor Tier 1, Tier 2, and Tier 3
4 Antiretroviral Protease Inhibitor Market by Type
  1. 4.1 Antiretroviral Protease Inhibitor Type Introduction
  2. 4.1.1 Amino Peptidase Inhibitor
  3. 4.1.2 Cysteine Protease Inhibitors
  4. 4.1.3 Metallo-Protease Inhibitors
  5. 4.1.4 Serine Protease Inhibitors
  6. 4.1.5 Aspartic Protease Inhibitors
  7. 4.1.6 Others
  8. 4.2 Global Antiretroviral Protease Inhibitor Sales by Type
  9. 4.2.1 Global Antiretroviral Protease Inhibitor Sales by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Antiretroviral Protease Inhibitor Sales by Type (2021-2032)
  11. 4.2.3 Global Antiretroviral Protease Inhibitor Sales Market Share by Type (2021-2032)
  12. 4.3 Global Antiretroviral Protease Inhibitor Revenue by Type
  13. 4.3.1 Global Antiretroviral Protease Inhibitor Revenue by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Antiretroviral Protease Inhibitor Revenue by Type (2021-2032)
  15. 4.3.3 Global Antiretroviral Protease Inhibitor Revenue Market Share by Type (2021-2032)
5 Antiretroviral Protease Inhibitor Market by Application
  1. 5.1 Antiretroviral Protease Inhibitor Application Introduction
  2. 5.1.1 Hospital Pharmacy
  3. 5.1.2 Online Pharmacy
  4. 5.1.3 Retail Pharmacy
  5. 5.1.4 Others
  6. 5.2 Global Antiretroviral Protease Inhibitor Sales by Application
  7. 5.2.1 Global Antiretroviral Protease Inhibitor Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Antiretroviral Protease Inhibitor Sales by Application (2021-2032)
  9. 5.2.3 Global Antiretroviral Protease Inhibitor Sales Market Share by Application (2021-2032)
  10. 5.3 Global Antiretroviral Protease Inhibitor Revenue by Application
  11. 5.3.1 Global Antiretroviral Protease Inhibitor Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Antiretroviral Protease Inhibitor Revenue by Application (2021-2032)
  13. 5.3.3 Global Antiretroviral Protease Inhibitor Revenue Market Share by Application (2021-2032)
6 Global Antiretroviral Protease Inhibitor Sales by Region
  1. 6.1 Global Antiretroviral Protease Inhibitor Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Antiretroviral Protease Inhibitor Sales by Region (2021-2032)
  3. 6.2.1 Global Antiretroviral Protease Inhibitor Sales by Region (2021-2026)
  4. 6.2.2 Global Antiretroviral Protease Inhibitor Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Antiretroviral Protease Inhibitor Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Antiretroviral Protease Inhibitor Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Antiretroviral Protease Inhibitor Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Antiretroviral Protease Inhibitor Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Antiretroviral Protease Inhibitor Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Antiretroviral Protease Inhibitor Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Antiretroviral Protease Inhibitor Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Antiretroviral Protease Inhibitor Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Antiretroviral Protease Inhibitor Revenue by Region
  1. 7.1 Global Antiretroviral Protease Inhibitor Revenue by Region
  2. 7.1.1 Global Antiretroviral Protease Inhibitor Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Antiretroviral Protease Inhibitor Revenue by Region (2021-2026)
  4. 7.1.3 Global Antiretroviral Protease Inhibitor Revenue by Region (2027-2032)
  5. 7.1.4 Global Antiretroviral Protease Inhibitor Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Antiretroviral Protease Inhibitor Revenue (2021-2032)
  8. 7.2.2 North America Antiretroviral Protease Inhibitor Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Antiretroviral Protease Inhibitor Revenue (2021-2032)
  11. 7.3.2 Europe Antiretroviral Protease Inhibitor Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Antiretroviral Protease Inhibitor Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Antiretroviral Protease Inhibitor Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Antiretroviral Protease Inhibitor Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Antiretroviral Protease Inhibitor Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Merck
  2. 8.1.1 Merck Company Information
  3. 8.1.2 Merck Business Overview
  4. 8.1.3 Merck Antiretroviral Protease Inhibitor Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Merck Antiretroviral Protease Inhibitor Product Portfolio
  6. 8.1.5 Merck Recent Developments
  7. 8.2 AbbVie
  8. 8.2.1 AbbVie Company Information
  9. 8.2.2 AbbVie Business Overview
  10. 8.2.3 AbbVie Antiretroviral Protease Inhibitor Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 AbbVie Antiretroviral Protease Inhibitor Product Portfolio
  12. 8.2.5 AbbVie Recent Developments
  13. 8.3 Tibotec
  14. 8.3.1 Tibotec Company Information
  15. 8.3.2 Tibotec Business Overview
  16. 8.3.3 Tibotec Antiretroviral Protease Inhibitor Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Tibotec Antiretroviral Protease Inhibitor Product Portfolio
  18. 8.3.5 Tibotec Recent Developments
  19. 8.4 Genentech, Inc.
  20. 8.4.1 Genentech, Inc. Company Information
  21. 8.4.2 Genentech, Inc. Business Overview
  22. 8.4.3 Genentech, Inc. Antiretroviral Protease Inhibitor Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Genentech, Inc. Antiretroviral Protease Inhibitor Product Portfolio
  24. 8.4.5 Genentech, Inc. Recent Developments
  25. 8.5 Bristol-Myers Squibb
  26. 8.5.1 Bristol-Myers Squibb Company Information
  27. 8.5.2 Bristol-Myers Squibb Business Overview
  28. 8.5.3 Bristol-Myers Squibb Antiretroviral Protease Inhibitor Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Bristol-Myers Squibb Antiretroviral Protease Inhibitor Product Portfolio
  30. 8.5.5 Bristol-Myers Squibb Recent Developments
  31. 8.6 Boehringer Ingelheim
  32. 8.6.1 Boehringer Ingelheim Company Information
  33. 8.6.2 Boehringer Ingelheim Business Overview
  34. 8.6.3 Boehringer Ingelheim Antiretroviral Protease Inhibitor Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Boehringer Ingelheim Antiretroviral Protease Inhibitor Product Portfolio
  36. 8.6.5 Boehringer Ingelheim Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Antiretroviral Protease Inhibitor Value Chain Analysis
  2. 9.1.1 Antiretroviral Protease Inhibitor Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Antiretroviral Protease Inhibitor Production Mode & Process
  6. 9.2 Antiretroviral Protease Inhibitor Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Antiretroviral Protease Inhibitor Distributors
  9. 9.2.3 Antiretroviral Protease Inhibitor Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst